Q2 2020 Holdings
Filed 2020-08-14 | 57 holdings | $218.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Springworks Therapeutics Inc | COM | 85205L107 | $96.0K | 2,286,891 | 0.0% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $4.7M | 1,742,112 | 2.2% |
| Black Diamond Therapeutics Inc(BDTX) | COM | 09203E105 | $16.0M | 378,788 | 7.3% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $26.0M | 3,115,537 | 11.9% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $35.6M | 2,740,000 | 16.3% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $46.6M | 1,882,722 | 21.4% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $87.8M | 390,000 | 40.3% |